ACAD insider trading
Acadia Pharmaceuticals Inc
In the past 68 days, 1 insider sold $69K.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
$69K 3,321 sh @ $20.88 |
−4.4% | Not pre-scheduled | Oct 30, 2026 Filed Oct 30, 2026 |
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.